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Lipid-enveloped viruses contain a lipid bilayer coat that protects their genome and helps
to facilitate entry into the host cell. Filoviruses are lipid-enveloped viruses that have up
to 90% clinical fatality and include Marbug (MARV) and Ebola (EBOV). These pleomorphic
ﬁlamentous viruses enter the host cell through their membrane-embedded glycoprotein
and then replicate using just seven genes encoded in their negative-sense RNA genome.
EBOV budding occurs from the inner leaﬂet of the plasma membrane (PM) and is driven by
the matrix proteinVP40, which is the most abundantly expressed protein of the virus. VP40
expressed in mammalian cells alone can trigger budding of ﬁlamentous virus-like particles
(VLPs) that are nearly indistinguishable from authentic EBOV.VP40, such as matrix proteins
from other viruses, has been shown to bind anionic lipid membranes. However, howVP40
selectively interacts with the inner leaﬂet of the PM and assembles into a ﬁlamentous lipid
enveloped particle is mostly unknown.This article describes what is known regardingVP40
membrane interactions and what answers will ﬁll the gaps.
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INTRODUCTION
The discovery of ﬁloviruses, Marburg virus (MARV) and Ebola
virus (EBOV) in 1967 and 1976, respectively, spread fear of new
pandemics that could spread globally and kill millions of people
(Dowdle, 1976; Johnson et al., 1977). While outbreaks have been
smaller for ﬁloviruses, the fatality can be as high as 90% and there
is some concern that a more signiﬁcant pandemic could be loom-
ing. EBOV and MARV are also classiﬁed as category A pathogens
by the NIH, a designation indicating they pose the highest risk
to public safety and national security. In addition, ﬁloviruses
may be found outside of sub-Saharan Africa (Marsh et al., 2011;
Negredo et al., 2011; Yuan et al., 2012), further underscoring the
need for new treatment options. To date, therapeutics or vaccines
have yet to be approved by the FDA for EBOV, but great strides
have been made toward this goal (Geisbert et al., 2010; Blaney
et al., 2013; Johansen et al., 2013; Pettitt et al., 2013; Warren et al.,
2014).
Filoviruses are lipid-enveloped, ﬁlamentous in shape, and har-
bor a negative-sense RNA genome. The genome encodes seven
proteins including nucleoprotein (NP), VP24, VP30, VP35, and
L protein, which constitute the nucleocapsid (NC; Olejnik et al.,
2011; Booth et al., 2013). The transmembrane glycoprotein (GP)
is rooted in the lipid envelope of the virus and is responsible for
entry of virions into the host cell (Lee et al., 2008; Cote et al., 2011;
Olejnik et al., 2011). VP40 (viral protein 40 kDa) is the EBOV
matrix protein, which regulates viral budding and NC recruit-
ment as well as virus structure and stability. Sole expression of
VP40 in mammalian cells is enough to assemble and form virus-
like particles (VLPs) that are similar in size, shape, and nearly
indistinguishable from the authentic virus (Jasenosky et al., 2001;
Timmins et al., 2001, 2003; Noda et al., 2002, 2006; Licata et al.,
2004). VP40 consists of 326 amino acids and has been shown to be
a peripheral protein (Jasenosky et al., 2001), which localizes to the
inner leaﬂet of the plasma membrane (PM) of human cells. Here,
VP40 oligomers guide formation of new viral particles (Timmins
et al., 2003; Adu-Gyamﬁ et al., 2012a, 2013; Bornholdt et al., 2013).
Although the molecular basis of VP40 membrane binding is not
well understood,mutations of VP40 that abrogate PM localization
(McCarthy et al., 2007; Adu-Gyamﬁ et al., 2013; Bornholdt et al.,
2013) or PM insertion (Adu-Gyamﬁ et al., 2013; Soni et al., 2013)
inhibit viral budding.
PLASMA MEMBRANE LIPIDS
The PM is an asymmetric bilayer that is approximately 30 Å
thick and contains ∼15% of its mass as transmembrane pro-
tein. A hallmark of PM asymmetry is an outer leaﬂet com-
posed mainly of phosphatidylcholine (PC), sphingomyelin (SM),
and glycosphingolipids and an inner leaﬂet enriched with
phosphatidylethanolamine (PE), phosphatidylserine (PS), phos-
phatidylinositol (PI), and phosphoinositides (PIPs; Schick et al.,
1976; Higgins and Evans, 1978; Venien and Le Grimellec, 1988;
van Meer et al., 2008; see Figure 1). Additionally, the PM is
enriched in cholesterol and by some accountsmay contain asmuch
as 50% of cholesterol (van Meer et al., 2008) although the distri-
bution of cholesterol among the outer and inner leaﬂets is not
as well understood. The PM inner leaﬂet contains ∼20–30 mol%
anionic lipid (McLaughlin et al., 2002; McLaughlin and Murray,
2005; Vance and Steenbergen, 2005; Vance and Tasseva, 2013),
which can attract peripheral proteins with cationic patches and
selective binding domains. The enrichment of PIPs, including
PI(4,5)P2 (McLaughlin et al., 2002; McLaughlin andMurray, 2005;
Balla, 2013), PI(4)P (Hammond et al., 2012), andPI(3,4,5)P3 (Heo
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FIGURE 1 | Chemical structures of lipids found in the PM
cytoplasmic leaflet. The inner leaﬂet of the PM has a relatively high
concentration of PE and PS and it is known to be enriched in
cholesterol and PI. Additionally, PIPs including PI(4)P, PI(4,5)P2, and
PI(3,4,5)P3 are found in low abundance in the PM inner leaﬂet but
have crucial roles in regulating peripheral protein localization and
function at the membrane interface. Structures are shown at
physiological pH.
et al., 2006)make up a small fraction of phospholipids on the inner
leaﬂet but play an important role in recruiting high-afﬁnity targets
and mediating electrostatic interactions.
PS is the most abundant anionic lipid in the cytosolic leaﬂet
at ∼15–20% (Vance and Steenbergen, 2005; Yeung et al., 2008;
Vance and Tasseva, 2013) and contributes to the recruitment of
polycationic proteins as well as proteins containing speciﬁc PS
binding domains (Cho and Stahelin, 2005, 2006). PS has also been
shown to interact with several viral matrix proteins (Zakowski
et al., 1981; Dick et al., 2012) as well as VP40 (Ruigrok et al.,
2000; Scianimanico et al., 2000; Adu-Gyamﬁ et al., 2013; Soni
et al., 2013). The coexistence of PS and PIPs in the same mem-
brane provides a mode of regulation for peripheral proteins that
bind weakly to just one anionic lipid. Coincidence detection,
which refers to recognition of two or more distinct membrane
lipids (Balla, 2005; Lemmon, 2008; Moravcevic et al., 2012; Scott
et al., 2012; Stahelin et al., 2014) has recently become a popular
model of peripheral protein recruitment to biological membranes
including that of HIV-1 Gag (Vlach and Saad, 2013). Addi-
tive and synergistic effects of either the anionic charge at the
PM, the presence of two distinct binding sites (e.g., PI(4,5)P2
and PS), or binding to a lipid in a region of positive curva-
ture can mediate the selective PM localization of some peripheral
proteins.
Membrane rafts are a common and controversial model of
membrane-related research. Rafts are enriched in cholesterol and
ordered membrane lipids with high-melting (Tm) temperatures
(Komura and Andelman, 2013; Sonnino and Prinetti, 2013).
Lipids are dynamic in bilayers and canmove and rotate in the plane
of themembrane,which can changewith variation in lipid compo-
sition and temperature. Membrane phase behavior describes these
lipid properties and is deﬁned as having the state of liquid-ordered
(Lo), liquid-disordered (Ld), or solid-gel (Lβ). The rafts in mem-
branes refer to the coexistence of the Lo and Ld phases. Lo phases
are enriched with cholesterol and lipids with saturated acyl chains
or a mixture of saturated and unsaturated acyl chains (Sonnino
and Prinetti, 2013). Ld phases, on the other hand, harbor unsat-
urated acyl chains and lower concentrations of cholesterol. The
unsaturated acyl chains are kinked and more spread out, leading
to a more loosely packed bilayer. The loose packing is not as favor-
able to shield cholesterol when compared to that of an ordered
and saturated membrane.
Several viruses including HIV (Ono and Freed, 2001;
Brugger et al., 2006;Waheed and Freed, 2009) and EBOV (Panchal
et al., 2003) have been suggested to bud from raft regions of the
PM. This is because viruses have been shown to be enriched with
cholesterol and sphingomyelin, be dependent upon membrane
cholesterol levels for budding (Ono et al., 2007), and associate
with the detergent-resistant fraction (Panchal et al., 2003) of cel-
lular membranes commonly associated with rafts. The PM outer
leaﬂet can harbor coexistence of Lo and Ld phases but as recently
and elegantly discussed in the context of HIV-1 Gag (Dick et al.,
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2012), it is important to note that the coexistence of Ld +Lo phases
has not been detected in bilayer models that more closely resem-
ble the PM inner leaﬂet (Wang and Silvius, 2001). Admittedly, in
vitro models are limited to more chemically simple lipid mixtures
than biological membranes but there are still many questions in
this ﬁeld including whether viral proteins themselves can induce
raft-like properties in the membrane.
VP40 INTERACTIONS WITH MEMBRANES
THE VP40 C-TERMINAL DOMAIN ASSOCIATES WITH PS-CONTAINING
MEMBRANES
The ﬁrst VP40 X-ray structure (Dessen et al., 2000) revealed
a matrix protein with an N-terminal domain that is impor-
tant for oligomerization (Timmins et al., 2003; Bornholdt et al.,
2013) and a C-terminal domain now shown to be essential
to membrane binding (Ruigrok et al., 2000; Scianimanico et al.,
2000; Jasenosky et al., 2001; Adu-Gyamﬁ et al., 2013; Born-
holdt et al., 2013; Soni et al., 2013). Ruigrok et al. (2000) ﬁrst
demonstrated that VP40 associated with lipid vesicles composed
of 25% PC, 50% PS, and 25% cholesterol using a VP40 con-
struct containing residues 31-326 (see also Table 1). They also
demonstrated that the VP40 C-terminal domain was an impor-
tant determinant of membrane binding as a truncated construct
(residues 31-212) has greatly reduced binding to the same PS-
containing vesicles. In these studies, 1 M NaCl was also able to
reduce association with the vesicles containing 50% PS. Addition-
ally, vesicles containing only 5% PS did not support signiﬁcant
VP40 binding. Taken together, C-terminal domain electrostatic
interacts seem to be a key determinant of anionic membrane
association.
Lipid vesicles containing PS have also been shown to induce
a conformational change in VP40 that results in hexamerization
(Scianimanico et al., 2000). This study used the same lipid com-
position noted above (25% PC, 50% PS, and 25% cholesterol) and
two VP40 constructs (31-319 and 31-326). Cross-linking demon-
strated dimer, trimer, tetramer, and hexamers formed for theVP40
31-319 construct. Cross-linking with PS liposomes exhibited no
detectable monomer but rather extensive oligomerization includ-
ing the large hexamer as the predominant band. It is also important
to note that they found 1% β-octyl-glucoside was needed to avoid
extensive VP40 aggregation in these assays. Hexamers were also
found exclusively localized in ﬁlopodia-like projections emanating
from the PM of human cells (Adu-Gyamﬁ et al., 2012a). In these
studies, total internal reﬂection ﬂuorescence (TIRF) microscopy
was used to selectively excite ﬂuorophores on or near the PM
interface. VP40 assembly and oligomerization into hexamers and
larger oligomers was clearly dependent on associationwith the PM
interface.
VP40 C-TERMINAL DOMAIN HYDROPHOBIC INTERACTIONS ARE
IMPORTANT FOR VLP FORMATION
In 2001, it was shown that VP40 alone formed VLPs from cells
(Jasenosky et al., 2001). These studies investigated VP40 and
respective truncation constructs’ ability to associate with cellu-
lar membranes. Triton X-114 detergent extraction was done in
order to separate the aqueous and detergent phase to inves-
tigate the mode of VP40 PM association. Integral membrane
proteins and lipidated proteins are found in the detergent phase,
while peripheral proteins reside in the aqueous phase of these
extractions. VP40 was found to be a peripheral protein as it
was almost exclusively extracted in the aqueous phase. Notably,
these authors propose the important role of hydrophobic inter-
actions of VP40 in membrane binding as they ﬁnd 1 M NaCl
did not release VP40 from the membrane bilayer. A hydropa-
thy plot demonstrated that the majority of VP40 hydrophobic
residues (Jasenosky et al., 2001) were in the last 50 residues of
the C-terminal domain, which was further supported with a
VP40 1-276 truncation. The low-to-moderate PM association of
this truncation (VP40 1-276) was perturbed by an increase in
the salt concentration. This is in contrast to the study discussed
above that demonstrated VP40 association with membranes was
driven by electrostatic interactions (Ruigrok et al., 2000). Note,
however, that those studies were done with PS-containing lipo-
somes and VP40 was not completely displaced from the vesi-
cles. Additionally, the PM bilayer is much more complex than
PC/PS/cholesterol liposomes and hydrophobic interactions may
play a more prominent role in locking VP40 into the PM inter-
face, where VP40 stays until the virions infect a new round of
cells.
VP40 OLIGOMERS ASSOCIATE WITH PLASMA MEMBRANE RAFTS
Membrane rafts have also been implicated in VP40 assembly and
oligomerization at the PM (Panchal et al., 2003). VP40 oligomers
were found exclusively associated in the membrane fraction, while
the soluble cytosolic fraction contained mostly monomeric VP40.
The raft fractions, which are also referred to as detergent-resistant
membranes (DRM), showed enrichment of VP40 oligomers. Sev-
eral truncations of VP40 were prepared including a 9-residue
C-terminal deletion (1-317) and an 18-residue C-terminal dele-
tion (1-308). The authors proposed that the C-terminal 9 amino
acids likely contribute to the membrane binding as this truncation
had less PM localization than wild type (WT). The 18-residue C-
terminal deletion had undetectable PM localization and formed
globules in the cytoplasm, which may be a sign of octameric
ring formation. Octamer formation has been shown to occur in
some mutations of the C-terminal domain, resulting in perinu-
clear globules (Bornholdt et al., 2013). This 18-residue truncation
additionallywas shown to be oligomeric, associatedwith the deter-
gent soluble fraction, and was unable to makeVLPs (Panchal et al.,
2003).
The authors identiﬁed proline 283 and proline 286 akin to an
SH3domain-binding site so theyweremutated to leucine (Panchal
et al., 2003). This resulted in oligomers in the cell lysate and the
detergent soluble fraction but exclusion from DRM. The proline
double mutant formed large aggregates in the cellular cytoplasm
as well. Additionally, no VLPs were generated for P283L/P286L.
Panchal et al. proposed that association with DRM is required
for release of VP40 VLPs and that residues 309–317 as well as
Pro283 and Pro286 are crucial for VP40 association with the PM
microdomains. It still is unclear how rafts, which are relatively
small in size compared to the EBOV virions, regulate budding
of ﬁlamentous particles that are a micron or more in length.
Moreover, thePM inner leaﬂet has not been shown toharbor a raft-
like composition further confounding how VP40 may assemble
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Table 1 | Summary ofVP40 mutations and truncations that have been assessed in the context of membrane binding or plasma membrane
association.
VP40 mutation or truncation In vitro membrane-binding effects Cellular ‘effects Reference
VP40 31-326 Associated with liposomes containing
50% PS and only weakly with
liposomes containing 5% PS; 1 M NaCl
signiﬁcantly reduced association with
liposomes containing 50% PS
Not measured Ruigrok et al. (2000)
VP40 31-326 Liposome association induces
hexamerization
Not measured Scianimanico et al. (2000)
VP40 31-319 In vitro liposome binding was enhanced
and induced hexamerization
Not measured Scianimanico et al. (2000)
VP40 1-326 Not measured A peripheral protein in the aqueous phase of a
TX-114 extraction; 1 M NaCl did not perturb
cellular membrane interactions indicating
hydrophobic interactions are important;
oligomers associated with membrane rafts
Jasenosky et al. (2001),
Panchal et al. (2003)
VP40 1-276 Not measured Greatly reduced association with cellular
membranes and no VLPs; membrane
association was sensitive to 1 M NaCl
Jasenosky et al. (2001)
VP40 1-318 Not measured Less PM association and VLP formation Panchal et al. (2003)
VP40 1-308 Not measured Globular oligomeric cytosolic structures
observed; no VLP formation
Panchal et al. (2003)
AAXY (P10A/P11A) Not measured Associates with membrane the same as WT
but cannot form VLPs
Jasenosky et al. (2001)
W95A Not measured Reduces oligomerization and budding Hoenen et al. (2010)
T112R Abolishes dimerization, forms
monomers and rings
Undetectable PM localization and budding Bornholdt et al. (2013)
L117R Abolishes dimerization, forms
monomers and rings
Undetectable PM localization and budding Bornholdt et al. (2013)
R134A Abolishes RNA binding Similar budding and PM localization; abolishes
RNA binding
Bornholdt et al. (2013)
212-KLR-214 mutations Not measured Altered cellular localization and oligomerization;
greatly reduced budding
McCarthy et al. (2007)
L213A Reduced penetration into plasma
membrane mimetic
Reduced PM localization and oligomerization McCarthy et al. (2007),
Adu-Gyamﬁ et al. (2013)
221-229 Not measured Abolished budding and PM localization Bornholdt et al. (2013)
K224E/K225E Not measured Abolished budding and PM localization Bornholdt et al. (2013)
K224M/K225M Not measured Abolished budding and PM localization Bornholdt et al. (2013)
K224R/K225R Not measured Restored budding and PM localization Bornholdt et al. (2013)
M241R Twisted hexamer is formed PM localization and membrane rufﬂing but no
VLP formation
Bornholdt et al. (2013)
K274A/275A Not measured Reduced budding but retains PM localization Bornholdt et al. (2013)
K274R/275R Not measured Restores budding Bornholdt et al. (2013)
P283L/P286L Not measured Cytosolic oligomers in the detergent soluble
fraction; no VLP formation
Panchal et al. (2003)
(Continued)
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Table 1 | Continued
VP40 mutation or truncation In vitro membrane-binding effects Cellular ‘effects Reference
I293A Reduced penetration into PM mimetic Greatly reduced PM localization,
oligomerization and budding
Adu-Gyamﬁ et al. (2013)
L295A Reduced penetration into PM mimetic Greatly reduced PM localization,
oligomerization and budding
Adu-Gyamﬁ et al. (2013)
V298A Reduced penetration into PM mimetic Greatly reduced PM localization,
oligomerization, and budding
Adu-Gyamﬁ et al. (2013)
A299W Used to assess VP40 depth of
membrane penetration (8.1 Å) and
binds membranes similar to WT
Localizes and buds similar to WT Soni et al. (2013)
I293A/A299W Signiﬁcantly reduced membrane
penetration
Reduced PM localization and abolished
budding
Soni et al. (2013)
L295A/A299W Signiﬁcantly reduced membrane
penetration
Reduced PM localization and abolished
budding
Soni et al. (2013)
I307R Induces ring formation No budding or PM localization. Globular
perinuclear structures observed.
Bornholdt et al. (2013)
and bud. One interesting and somewhat related possibility is the
location of PS on the PM inner leaﬂet. Recently, it was shownusing
the robust PS sensor lactadherin C2 that PS is clustered and asso-
ciated with caveolae in the PM inner leaﬂet (Fairn et al., 2011),
which may explain VP40 oligomers being localized to DRM. A
careful examination of the EBOV lipidome would help resolve
some of these questions.
VP40 CAN PENETRATE INTO THE PLASMAMEMBRANE HYDROCARBON
CORE
To investigate if hydrophobic interactions are important for VP40
association with membranes in vitro, a lipid monolayer assay was
employed (Adu-Gyamﬁ et al., 2013). Lipid monolayers are a useful
platform for assessing the ability of peripheral proteins to pene-
trate into membranes of a lipid composition the experimentalist
chooses (Cho et al., 2001). Biological membranes and lipid vesi-
cles have surface pressures in the 30–35 mN/m range (Demel et al.,
1975; Marsh, 1996), so proteins that are thought to penetrate
under physiological conditions usually have a critical pressure (πc)
above 30 mN/m. The ability of VP40 to penetrate into mono-
layers that served as a mimetic of the cytoplasmic face of the
PM (PC:PE:PS:PI:cholesterol (12:35:22:9:22)) or the nuclear enve-
lope (PC:PE:PS:PE:cholesterol (61:21:4:7:7); Stahelin et al., 2003b)
was assessed. In brief, VP40 was able to penetrate signiﬁcantly
into the PM mimetic (πc ∼ 34 mN/m) compared to that of the
nuclear membrane mimetic (πc ∼ 25 mN/m; Adu-Gyamﬁ et al.,
2013).
To investigate the molecular basis of VP40-mediated penetra-
tion, the authors used the rationale that the C-terminal domain
undergoes hydrophobic interactions with the membrane bilayer
within the last 50 amino acids (Jasenosky et al., 2001). Exam-
ining the structure of the VP40 C-terminal domain revealed a
loop region rich in hydrophobic residues (Ile293, Leu295, and
Val298) conserved among the EBOV strains. A control mutation
of Leu303 that was previously shown to interact with Sec24C
(Yamayoshi et al., 2008) was also prepared. It was also noted that
Leu213, which was previously shown to be important for VP40
PM localization and oligomerization (McCarthy et al., 2007), was
on the same interface as Ile293, Leu295, and Val298. Thus, L213A
was also prepared. L213A, I293A, L295A, and V298A all exhib-
ited greatly reduced penetration into the PM mimetic indicating
these residues are important for docking into lipid membranes.
L303A, however, did not inﬂuence the ability of VP40 to pen-
etrate into the PM mimetic. The effects of these hydrophobic
mutations on VP40 PM localization, oligomerization in cells, and
the ability to form VLPs were examined. In consonance with
in vitro penetration data L213A, I293A, L295A, and V298A all
had signiﬁcantly reduced PM localization. This indicated that
membrane penetration by this hydrophobic interface is impor-
tant for the localization and latching on of VP40 to the PM
bilayer. Single-molecule imaging using TIRF demonstrated that
membrane penetration is an important step in VP40 oligomer-
ization as these mutations abolished detectable hexamerization of
VP40. Finally, these mutations also had greatly diminished VLP
formation signifying the importance of this region in ﬁlamentous
particle formation. The control mutation, L303A, behaved similar
to WTVP40 in all cellular experiments. Importantly, hydrophobic
mutations did not exhibit globular cytosolic structures, which are
usually indicative of octameric ring formation (Bornholdt et al.,
2013).
VP40 CAN DEEPLY PENETRATE THE PLASMA MEMBRANE AND INDUCE
MEMBRANE CURVATURE CHANGES
To dig deeper into the mechanism of VP40-mediated membrane
penetration, a Trp residue was introduced at Ala299 within the
hydrophobic loop (Soni et al., 2013). Trp is advantageous as its
ability to ﬂuoresce can be used in combination with bromi-
nated lipids to determine the depth of penetration of peripheral
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proteins. Brominated lipids are available with bromine on dif-
ferent positions of the acyl chain so their ability to quench
Trp in the lipid-binding site can be compared using depth-
dependent ﬂuorescence quenching proﬁles (DFQP). Since the
depth of bromine positions have been calibrated using X-ray
diffraction (McIntosh and Holloway, 1987; Kleinschmidt and
Tamm, 1999), the depth of Trp was determined using the dis-
tribution analysis (DA) method (Ladokhin, 1997, 1999). It is
important to note that VP40 and A299W had similar afﬁnity
for PS liposomes, PM localization, oligomerization, and A299W
retained the ability to form VLPs. Lipids with bromine on the
9th and 10th carbons were most efﬁcient at quenching A299W
indicating their proximity to the residues in this hydrophobic
loop region. The DA calculation determined the mean depth
of VP40 penetration to be 8.1 Å, which is more than halfway
through one leaﬂet of the bilayer. In vitro and cell experi-
ments demonstrated that introducing less hydrophobic mutations
into the A299W construct (I293A/A299W and L295A/A299W)
lead to poor penetration into the hydrocarbon core, reduced
PM localization, and very low levels of VLP formation (Soni
et al., 2013). These data indicated that loss of perhaps even one
key hydrophobic contact would reduce viral egress. Electron
microscopy (EM) and giant unilamellar vesicle (GUV) imaging
demonstrated that VP40 induced negative membrane curvature
changes in a PS-dependent manner. This type of curvature gener-
ation is consistent with VP40 pushing the inner leaﬂet of the PM
out of the cell to form a VLP. As expected from the other assays,
hydrophobic mutations reduced the ability of VP40 to induce
membrane curvature changes. These studies suggestedVP40 plays
a major role in remodeling the PM shape to form the ﬁlamentous
VLP.
VP40 MEMBRANE INTERACTION SUMMARY
These cellular and in vitro membrane-binding studies on VP40
have revealed some of the important processes that regulate VP40
PM localization and VLP formation. VP40 has both electrostatic
and hydrophobic components to its membrane interaction that
are important to VLP formation. Notably, the C-terminal domain
of VP40 deeply penetrates the PM, which can induce negative
curvature changes in synthetic membranes (Soni et al., 2013).
Membrane association of VP40 also appears to be a prerequisite to
inducing hexamerization (Scianimanico et al., 2000; Adu-Gyamﬁ
et al., 2012a, 2013; Bornholdt et al., 2013). On the other hand,
taken together these studies demonstrate there is still dearth of
information on how VP40 associates with the PM inner leaﬂet.
Remarkably, it appears VP40 lipid selectivity has not been system-
atically and carefully investigated. This is of utmost importance
when the complex chemical composition of the PM inner leaﬂet
is considered. Moreover, many peripheral proteins have been
shown to undergo a complex set of interactions with membrane
bilayers in order to achieve membrane docking and membrane
curvature generation (Balla, 2005; Lemmon, 2008; Moravcevic
et al., 2012; Scott et al., 2012; Mim and Unger, 2012; Stahelin
et al., 2014). Thus, more detailed biochemical and biophysical
investigation at the membrane interface is warranted to eluci-
date how VP40–lipid interactions mediate ﬁlamentous particle
formation.
VP40 STRUCTURES REVEAL THE BASIS OF
OLIGOMERIZATION AND MEMBRANE BINDING
Recently, Bornholdt et al. (2013) solved several EBOV VP40 high-
resolution structures that demonstrated VP40 can transform into
multiple arrangements. These distinct VP40 structures have sep-
arate but critical roles in the life cycle of the virus (Bornholdt
et al., 2013). VP40 was revealed to be a dimer (see Figure 2) where
each dimer serves as a building block that can further assemble
into a ﬂexible ﬁlamentous matrix protein structure (Bornholdt
et al., 2013). VP40 dimerization is mediated by a hydrophobic N-
terminal domain (NTD) interface, which when mutated, leads
to abolishment of PM localization and VLP formation (Born-
holdt et al., 2013). VP40 dimers, which are oblong, form linear
ﬁlaments that have a hydrophobic C-terminal domain (CTD)
interface (Bornholdt et al., 2013). These hexamers may further
multimerize into a lattice or ﬁlamentous structure (Bornholdt
et al., 2013) that regulates EBOVbudding and virion shape. A third
interface containing Trp95 was revealed following incubation with
dextran sulfate, which was used as an anionic membrane mimetic
(Bornholdt et al., 2013). This third interface is also important to
assembly and budding as previous mutation of Trp95 diminished
oligomerization and egress (Hoenen et al., 2010). VP40 dimers
and hexamers may interact laterally through this third interface
(Trp95), which would be more accessible after membrane bind-
ing, to form a highly dense ﬁlament (Bornholdt et al., 2013). VP40
can also form an octameric ring, which binds RNA and func-
tions in viral transcription inside the cell (Bornholdt et al., 2013).
The octameric ring is not recruited into VLPs or infectious viri-
ons and if or how it interacts with cellular membranes is still
unknown.
VP40 DIMERS INTERACT THROUGH A HYDROPHOBIC NTD INTERFACE
The interface in the NTD of VP40 buries ∼1500–1700 Å2 in the
dimer (Bornholdt et al., 2013). This involves α-helices contain-
ing residues 52–65 and 108–117 (Bornholdt et al., 2013). The
NTD interactions are primarily hydrophobic and have few H-
bonds. This interaction network speciﬁcally involves Ala55, His61,
Phe108, Thr112,Ala113,Met116, and Leu117 (Bornholdt et al., 2013).
Leu117 was found to be a key residue in the NTD interaction.
This Leu extends into a hydrophobic pocket (Ala55, His61, Met116,
and Phe108) to lock the dimer together (Bornholdt et al., 2013).
This NTD interface is also much different than the interface that
mediates the RNA-binding octameric ring (Gomis-Rüth et al.,
2003). In order to form the octameric ring from the VP40 dimer,
large conformational changes are necessary including movement
of the C-terminal domain as well as extensive unraveling of the
N-terminal 69-amino acids (Bornholdt et al., 2013). T112R and
L117R abrogate the dimer formation and form monomers and
octameric ring structures (Bornholdt et al., 2013). Neither mutant
is released as VLPs and PM localization for the most part is
undetectable (Bornholdt et al., 2013).
VP40 DIMERS FORM FILAMENTOUS HEXAMERS THROUGH A
HYDROPHOBIC CTD INTERFACE
In all crystal structures of VP40 solved with the CTD visible,
the CTD formed CTD-to-CTD interfaces that are hydrophobic
and involved residues Leu203, Ile237, Met241, Met305, and Ile307
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FIGURE 2 |VP40 structural analysis. VP40 is a dimer (Bornholdt et al.,
2013) that is the building block for VP40 ﬁlament formation. Dimerization
is mediated by a hydrophobic N-terminal domain interface (Bornholdt
et al., 2013). The dimeric structure revealed a robust cationic patch
exposed on one face of the dimer (Bornholdt et al., 2013) Mutation of
Lys residues in this C-terminal domain cationic patch greatly reduced
PM localization and budding in cells and is surmised to mediate
membrane binding (Bornholdt et al., 2013). Adjacent to the cationic patch
is a hydrophobic loop in the C-terminal domain that mediates membrane
insertion of VP40, an important step for VP40 PM binding and
membrane curvature generation (Adu-Gyamﬁ et al., 2013; Soni et al.,
2013).
(Bornholdt et al., 2013). These interactions allowed VP40 dimers
to form ﬁlamentous structures. The structure revealed this inter-
face to have torsional motion, perhaps an important property
in forming a ﬂexible and ﬁlamentous structure from PM lipids
(Bornholdt et al., 2013). Met241 was mutated as it resides at the
center of the interface but is not essential to the fold of the CTD.
M241R was generated, is dimeric in solution, and does not bud
VLPs (Bornholdt et al., 2013). However, membrane rufﬂing was
observed for M241R indicating the dimer is the building block to
induce membrane curvature changes (Bornholdt et al., 2013). The
M241R structure was solved to 4.15 Å resolution, which further
demonstrated that this mutation did not disrupt the fold of the
dimer but forced packing of dimerswith a twisted interface relative
to that of WT (Bornholdt et al., 2013). In the twistedM241R struc-
ture, the CTD interface harbored residues Leu203 and Ile307 at the
center of the interface rather than Met241 (Bornholdt et al., 2013).
M241R also prevented rotation about the CTD–CTD interface
(Bornholdt et al., 2013) suggesting that a fairly precise hexamer
with proper torsional motion is necessary to form ﬁlamentous
particles via PM bending.
VP40 OCTAMERIC RINGS CAN BE INDUCED BY THE I307R MUTATION
I307R was made to investigate the CTD interface further but
demonstrated extensive formation of octameric rings that are
bound to nucleic acid (Bornholdt et al., 2013). In cells, I307R
is not detectable at the PM but instead forms globular struc-
tures that are perinuclear (Bornholdt et al., 2013). Octameric
ring formation thus blocked budding of VLPs (Bornholdt et al.,
2013). Gln309 was mutated as a control for Ile307 and behaved
similar to WT (Bornholdt et al., 2013) while R134A was pre-
pared to knockout RNA binding (Gomis-Rüth et al., 2003).
R134A behaved similar to WT in PM localization and bud-
ding and formed a dimer in solution (Bornholdt et al., 2013).
The double mutant, R134A/I307R, was made to prevent CTD-
mediated ﬁlament assembly where the R134A component would
prevent RNA binding and thus octameric ring formation. As
expected, R134A/I307R is a nucleic-acid-free dimer in solution
and no longer forms globular structures that are perinuclear
in cells (Bornholdt et al., 2013). Instead, this double mutant
translocates to the PM but does not bud or form VLPs as it
cannot form effective hexamers (Bornholdt et al., 2013). While
PM localization is evident for R134A/I307R, membrane ruf-
ﬂing is not like that of the M241R mutation (Bornholdt et al.,
2013). Overall, their modeling studies suggested that I307R pro-
hibits CTD-to-CTD interactions while M241R permits them
but with twisted and defective interactions (Bornholdt et al.,
2013).
A CATIONIC C-TERMINAL DOMAIN INTERFACE IS REVEALED
These new VP40 structures also revealed a disordered loop in
the C-terminal domain that contains several positively charged
residues (Bornholdt et al., 2013). A cationic patch in the CTD is
electrostatically important for binding the PM and forming VLPs
(Bornholdt et al., 2013). The basic patch in the CTD is exposed
and made up of six Lys residues (Lys221, Lys224, Lys225, Lys270,
Lys274, and Lys275; Bornholdt et al., 2013) some of which are in
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a loop region not previously observed in the original structure
(Dessen et al., 2000). This patch is also conserved across the ﬁve
species of EBOV. A 10-amino-acid loop deletion (221−229) that
included removal of Lys221, Lys224, and Lys225 lead to abroga-
tion of budding but the dimeric structure was still maintained
(Bornholdt et al., 2013). Mutations of Lys224 and Lys225 to Met or
Glu abrogated PM localization and budding but when mutated to
Arg retained WT function (Bornholdt et al., 2013). K274E/K275E
exhibited little formation of VLPs but some translocation to the
PM interface (Bornholdt et al., 2013). Restoration of positive
charge to this region (K274R/K275R) was able to recover VLP
formation at WT levels (Bornholdt et al., 2013). These C-terminal
domain basic charges are necessary for budding and it is impor-
tant to note that these cationic residues are not essential to the
structure or any known protein–protein interfaces. It should
also be noted that these loop regions harbor several Asn and
Ser residues that could H-bond with PM lipid headgroups. The
cationic residues are exposed on one side of the dimer and
also adjacent to the hydrophobic residues previously shown to
penetrate into the PM hydrocarbon core (Figure 2). Together
they may form a robust interface for PM docking (Stahelin,
2014).
CONCLUSION AND FUTURE PERSPECTIVES
VP40 MEMBRANE BINDING MODEL
VP40 may be somewhat similar to the VSV matrix protein, which
has been shown to engage in both electrostatic and hydrophobic
interactions with lipid membranes (Ye et al., 1994; Gaudier et al.,
2002). Taking into account the lipid-binding studies performed
on VP40 and the new structural information that has become
available, a rough membrane-binding model can be proposed (see
Figure 3). In the ﬁrst step of PM binding, the electrostatic patch
in the C-terminal domain likely mediates the membrane associa-
tion step with the highly anionic PM interface. The VP40 dimer
would be advantageous in this regard as it would have enhanced
avidity for the membrane compared to a VP40 monomer with
only one cationic patch. Whether or not this patch directly coor-
dinates speciﬁc lipid headgroups is unknown, but in the case of PS
binding would induce VP40 hexamerization (Scianimanico et al.,
2000). This structural rearrangement would allow the penetration
and docking of the C-terminal hydrophobic loop into the PM, so
VP40 could lock in the membrane for the ride out of the cell.
How does PM binding induce VP40 hydrophobic penetration?
This is still unknown but some peripheral proteins have been
shown to coordinate a lipid headgroup to decrease the desolva-
tion penalty associated with hydrophobic membrane insertion
(Stahelin et al., 2002, 2003a). The VP40 hexamer or longer ﬁl-
ament that concatenates may then provide the energetic force
necessary to induce negative membrane curvature generation
from the PM interface. The studies by Bornholdt et al. (2013)
provided a very attractive model for understanding this process
as the M241R mutation that alters torsional motion of the VP40
hexamer demonstrates extensive membrane protrusions from the
PM.However, thismutant lacked effectiveVLP formation suggest-
ing an inability to undergo scission (Bornholdt et al., 2013). Thus,
the VP40 hexamer may be the driving force for negative mem-
brane curvature generation and formation of PM protrusions but
without proper torsional motion across the CTD interface VP40
may not effectively further multimerize longitudinally or later-
ally to either drive effective VLP formation or alter interactions
with the ESCRT complex, which may be needed for efﬁcient VLP
release. The elegant proposal by Bornholdt et al. (2013) which
accounted for the precise location of VP40 between the viral lipid
envelope and nucleocapsid, proposed that VP40 C-termini point
out from both planes of a VP40 lattice engaging both the lipid
envelope and viral RNA. This model may also help explain how
VP40 achieves initial membrane curvature generation as some
C-termini would be deeply engaged in the membrane hydropho-
bic core while the C-termini in the opposite plane would interact
with RNA (Bornholdt et al., 2013). As VP40 interacts both later-
ally and longitudinally beneath the PM (Bornholdt et al., 2013),
the dual engagement of membrane and RNA by two C-terminal
interfaces may provide the driving force for PM protrusion and
virus structure.
Protein–protein interactions may also play an important role in
VP40 assembly and egress and cannot be discounted in these mod-
els.VP40may associatewith actin (Han andHarty,2005), IQGAP1
(Lu et al., 2013), Sec24C (Yamayoshi et al., 2008), and micro-
tubules (Ruthel et al., 2005). Additionally, actin has been shown to
regulate ballistic motion of VP40, where inhibition of actin poly-
merization lead to constrained diffusion of VP40 molecules on the
PM (Adu-Gyamﬁ et al., 2012b). The roles these interactions play
are only beginning to be unraveled and a comprehensive view of
VP40–protein and VP40–lipid interactions could help resolve the
molecular details of EBOV assembly and budding.
IS VP40 AN ANIONIC CHARGE SENSOR OR DOES IT SPECIFICALLY BIND
LIPID HEADGROUPS?
To date, the lipid selectivity and membrane afﬁnity of VP40 is
still unknown. Several studies, as outlined in this review, have
shown that VP40 can associate with, penetrate, and hexamerize
in response to interactions with PS-containing liposomes. How-
ever, many peripheral proteins have distinct lipid selectivity and
binding sites for lipid headgroups including those of PS and PIPs
(Cho and Stahelin, 2005; Lemmon, 2008; Huang et al., 2011; Lucas
and Cho, 2011). Additionally, many lipid-binding proteins are
coincidence detectors and interact with two distinct lipid head-
groups or a lipid and membrane physical property such as charge
or curvature (Balla, 2005; Lemmon, 2008; Mim and Unger, 2012;
Moravcevic et al., 2012; Scott et al., 2012; Stahelin et al., 2014).
More systematic analysis of VP40 lipid selectivity is needed to
discover the optimal lipid composition that VP40 interacts with.
This is especially important considering the complex chemistry of
the PM lipid environment including important PM lipids, such
as PS, PE, PI, cholesterol, and PIPs. Additionally, lipid acyl chain
length and saturation can vary at the PM, which may also play
an important role in VP40 PM detection and membrane curva-
ture generation. As a VP40 budding particle is formed relatively
ﬂat membrane curvature is generated along the particle trajectory,
while the neck region extending from the PM contains a region
of negative curvature. Perhaps, the VP40 hexamers and ﬁlaments
that form becomes activated in the sense they assemble on the
more negatively curved membrane neck region. In other words,
perhaps distinct VP40 structures have selectivity for the shape of
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FIGURE 3 | Plasma membrane binding model forVP40. Considering
previous studies and available data on VP40 structure and membrane-binding
properties a simpliﬁed model of VP40 association with the PM is proposed.
The VP40 dimer, which contains a large cationic solvent exposed patch in the
C-terminal domain likely mediates the association of VP40 with the highly
anionic interface of the PM. VP40 interactions with PS (Ruigrok et al., 2000;
Scianimanico et al., 2000; Adu-Gyamﬁ et al., 2013; Soni et al., 2013) and
perhaps other lipids such as PIPs induce a conformational change of VP40
rearranging the dimers into a zigzagging hexamer (Bornholdt et al., 2013). The
VP40 dimers can interconnect through the CTD to form linear hexamers as
well (Bornholdt et al., 2013). These hexamers have “sticky” ends that can
further interact to form long VP40 ﬁlaments (Bornholdt et al., 2013). Lateral
interactions between VP40 ﬁlaments are also possible and can occur
between dimers and hexamers (Bornholdt et al., 2013). Note, in this model a
VP40 monomer would not robustly interact with the PM (Bornholdt et al.,
2013) presumably due to weak afﬁnity or lack of transport to the PM.
Hydrophobic interactions between the more liberated (Bornholdt et al., 2013)
C-terminal domain hydrophobic loop (Jasenosky et al., 2001; Adu-Gyamﬁ
et al., 2013; Soni et al., 2013) and the PM hydrophobic core act to increase the
membrane residence time of VP40. As VP40 assembles on the inner leaﬂet of
the PM, the C-terminal hydrophobic residues are able to penetrate ∼8.1Å.
VP40 oligomers are able to induce budding (negative membrane curvature
generation; Soni et al., 2013) of a ﬁlamentous particle that eventually will
undergo scission and be released.
the PM. In time these questions will likely be answered but will
require robust biochemical and biophysical investigation of VP40
lipid-binding and -bending properties. These analyses should
also include the lipid-binding determinants of VP40 zigzagging
hexamer formation.
For the sake of comparison, it should be noted that the
matrix domain of HIV-1, which has been known to associate
with PM PI(4,5)P2 (Ono et al., 2004) has more recently been
shown to undergo a complex set of interactions with the PM that
includes roles for lipid acyl chain saturation (Dick et al., 2012),
lipid headgroup structure (Vlach and Saad, 2013), and protein
oligomerization (Dick et al., 2013). Notably, PS/PE/PC have been
shown tobind theHIV-1matrix domain at a different site than that
of PI(4,5)P2 (Vlach and Saad, 2013). HIV-1 matrix has also been
shown to be sensitive to the saturation on the acyl chains of PS and
cholesterol content in lipid vesicles (Dick et al., 2012). Thus, viral
matrix proteins likely use a complex set of chemical interactions
with the membrane to regulate the spatial and temporal assembly
of viral particles. This may also be important when considering
formation of long and ﬂexible EBOV ﬁlamentous particles.
CAN VP40 INDUCE FLIPPING OF PS?
A number of viruses including EBOV have now been shown to
utilize PS exposed on the outer membrane envelope of the virus
to facilitate entry into target cells (Soares et al., 2008; Jemielity
et al., 2013; Morizono and Chen, 2014). PS interacts with the
TIM-1 receptor on human cells and inhibition of PS exposure
or PS availability to interact with the TIM-1 receptor, may be of
great therapeutic value in a number of viral infections (Jemielity
et al., 2013; Moller-Tank et al., 2013; Morizono and Chen, 2014).
Strikingly,VP40VLPs lacking theGP are able to enter target cells in
a PS-dependent manner (Jemielity et al., 2013; Moller-Tank et al.,
2013). This suggests that the information encoding PS exposure
in VLPs may be encoded in VP40 alone. The PM asymmetry in
eukaryotic cells is kept intact by ATP-dependent aminophospho-
lipid ﬂippases (Daleke, 2007; Baldridge and Graham, 2012), which
keep PE and PS concentrated on the PM inner leaﬂet. Studies on
erythrocytes have shown that >96% of PS is on the inner leaﬂet
(Zachowski, 1993) meaning only 4% or less is exposed to the outer
leaﬂet. While the percentage of PS exposure natively on most cell
types is not known, it is not expected to be high. Is 4% PS on
the outer ﬁlovirus envelope enough molecules of PS to facilitate
entry? Perhaps, however, how, when, and how much PS is exposed
on viral particles is unknown. This leads the author to speculate
that PS may become more signiﬁcantly exposed on VP40 VLPs or
EBOV virions. Several possibilities exist: (i) Curvature generation
in vesicular transport from the Golgi has been shown to expose
(ﬂip) PS in budding vesicles (Xu et al., 2013), whichmay also occur
as theVP40 bud site is formed. (ii)VP40VLPs may restrict or limit
incorporation of ﬂippases and along with lack of ATP in the VLPs
leads to some loss of asymmetry. (iii) Calcium-dependent scram-
blases may become active in the plasma membrane (Zhou et al.,
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1997) or inVLPs. Lipid scramblases are still a controversial subject
but in some studies have been shown to randomize the lipid dis-
tribution across the PM. Given the important nature of PS in viral
entry, these are some potential lines of investigation to explore. We
still have a lot to learn regarding VP40-mediated assembly of the
EBOV envelope but there are many exciting endeavors to pursue
in the lipid ﬁeld along the way.
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